Open Lab as a source of hits and leads against tuberculosis, malaria and kinetoplastid diseases

Lluís Ballell; Mike Strange; Nicholas Cammack; Alan H. Fairlamb; Leszek Borysiewicz

doi:10.1038/nrd.2016.51

Open Lab as a source of hits and leads against tuberculosis, malaria and kinetoplastid diseases

Lluís Ballell (Lead / Corresponding author)
, Mike Strange
, Nicholas Cammack
, Alan H. Fairlamb
, Leszek Borysiewicz

Biological Chemistry and Drug Discovery

Research output: Contribution to journal › Letter › peer-review

9 Citations (Scopus)

Original language	English
Article number	292
Number of pages	3
Journal	Nature Reviews Drug Discovery
Volume	15
Issue number	4
Early online date	29 Mar 2016
DOIs	https://doi.org/10.1038/nrd.2016.51
Publication status	Published - Apr 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Animals
Developing countries
Drug discovery
Foundations
Humans
Malaria
Neglected diseases
Tuberculosis
Comment
Letter

Access to Document

10.1038/nrd.2016.51

Cite this

@article{53804891768946669c796bab85a870a7,

title = "Open Lab as a source of hits and leads against tuberculosis, malaria and kinetoplastid diseases",

keywords = "Animals, Developing countries, Drug discovery, Foundations, Humans, Malaria, Neglected diseases, Tuberculosis, Comment, Letter",

author = "Llu{\'i}s Ballell and Mike Strange and Nicholas Cammack and Fairlamb, \{Alan H.\} and Leszek Borysiewicz",

year = "2016",

month = apr,

doi = "10.1038/nrd.2016.51",

language = "English",

volume = "15",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Research",

number = "4",

}

TY - JOUR

T1 - Open Lab as a source of hits and leads against tuberculosis, malaria and kinetoplastid diseases

AU - Ballell, Lluís

AU - Strange, Mike

AU - Cammack, Nicholas

AU - Fairlamb, Alan H.

AU - Borysiewicz, Leszek

PY - 2016/4

Y1 - 2016/4

KW - Animals

KW - Developing countries

KW - Drug discovery

KW - Foundations

KW - Humans

KW - Malaria

KW - Neglected diseases

KW - Tuberculosis

KW - Comment

KW - Letter

U2 - 10.1038/nrd.2016.51

DO - 10.1038/nrd.2016.51

M3 - Letter

C2 - 27020099

SN - 1474-1776

VL - 15

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

IS - 4

M1 - 292

ER -